Cargando…
Study of dosimetry and clinical factors for assessment of xerostomia in head and neck squamous cell carcinoma treated by intensity-modulated radiotherapy: A prospective study
AIM: Clinical and dosimetric factors related to toxicity in terms of xerostomia in patients with head and neck squamous cell cancer (HNSCC) treated with intensity-modulated radiotherapy (IMRT). MATERIALS AND METHODS: Patients older than 18 years, with the WHO Performance Status Score <2 with prim...
Autores principales: | Singla, Vrinda, Nautiyal, Vipul, Gupta, Meenu, Kumar, Viney, Mehra, Shivani, Ahmad, Mushtaq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511834/ https://www.ncbi.nlm.nih.gov/pubmed/34729046 http://dx.doi.org/10.4103/jcar.JCar_5_21 |
Ejemplares similares
-
Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study
por: Onjukka, Eva, et al.
Publicado: (2020) -
Impact of xerostomia on the quality of life of patients submitted to head and neck radiotherapy
por: do Nascimento, Michele Lopes, et al.
Publicado: (2019) -
Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy for head and neck squamous cell carcinoma is not affected by xerostomia
por: Palmieri, Michelle, et al.
Publicado: (2018) -
Dosimetry of Submandibular Glands on Xerostomia for Nasopharyngeal Carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2021) -
Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia
por: Castelli, Joel, et al.
Publicado: (2015)